Journal of Translational Internal Medicine最新文献

筛选
英文 中文
Anti-SIA-cIgG enhances chemotherapy effectiveness through PTPN13-regulated tumor stemness in head and neck squamous cell carcinoma. 抗sia - cigg通过ptpn13调控的头颈部鳞状细胞癌肿瘤干性提高化疗效果。
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-03-26 eCollection Date: 2026-04-01 DOI: 10.1515/jtim-2026-0040
Luming Wang, Yangyang Xia, Chenshu Liu, Xiaofeng Shan, Yi Sui, Shang Xie, Zhigang Cai
{"title":"Anti-SIA-cIgG enhances chemotherapy effectiveness through PTPN13-regulated tumor stemness in head and neck squamous cell carcinoma.","authors":"Luming Wang, Yangyang Xia, Chenshu Liu, Xiaofeng Shan, Yi Sui, Shang Xie, Zhigang Cai","doi":"10.1515/jtim-2026-0040","DOIUrl":"https://doi.org/10.1515/jtim-2026-0040","url":null,"abstract":"<p><strong>Background and objectives: </strong>The chemotherapy response rate in head and neck squamous cell carcinoma (HNSCC) remains low due to a lack of effective therapeutic targets, and treatment efficacy is further limited by chemoresistance and heterogeneity in drug response. Sialylated cancer IgG (SIA-cIgG) is a tumor-derived immunoglobulin implicated in tumor stemness. However, the relationship between SIA-cIgG and chemoresistance, and its potential as a therapeutic target, remain to be determined.</p><p><strong>Methods: </strong>We evaluated the antitumor eficacy of SIA-cIgG inhibition combined with four chemotherapeutic agents using two HNSCC cell lines with high or low SIA-cIgG expression, along with in vivo xenograft models. Furthermore, we investigated the functional roles of SIA-cIgG and its downstream effector PTPN13 in regulating HNSCC stemness. Patient-derived organoids (PDOs) from 25 HNSCC patients were used to compare the antitumor eficacy of anti-SIA-cIgG-based combinations against conventional clinical chemotherapy regimens.</p><p><strong>Results: </strong>Elevated SIA-cIgG protein levels correlated positively with an increased IC50 for cisplatin and poorer chemotherapy response. SIA-cIgG/PTPN13 axis was critical for tumor stemness and chemoresistance. Anti-SIA-cIgG treatment enhanced PTPN13 protein stability and upregulated PTPN13 mRNA expression via SP1. Anti-SIA-cIgG-based drug combinations demonstrated significantly higher anticancer efficacy than conventional clinical chemotherapy regimens and overcame tumor heterogeneity in drug response.</p><p><strong>Conclusions: </strong>SIA-cIgG/PTPN13 axis regulates tumor stemness and contributes to chemoresistance, anti-SIA-cIgG-based drug combinations exhibit significant potential for clinical application.</p>","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 2","pages":"237-258"},"PeriodicalIF":7.4,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13110467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147787838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reframing sepsis research through translational integrative models. 通过翻译整合模型重构败血症研究。
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-18 eCollection Date: 2026-02-01 DOI: 10.1515/jtim-2026-0017
Dandan Zhu, Krzysztof Laudanski
{"title":"Reframing sepsis research through translational integrative models.","authors":"Dandan Zhu, Krzysztof Laudanski","doi":"10.1515/jtim-2026-0017","DOIUrl":"https://doi.org/10.1515/jtim-2026-0017","url":null,"abstract":"","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 1","pages":"1-5"},"PeriodicalIF":7.4,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147272842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sirolimus-based induction therapy for lupus nephritis: A single-arm, open-label pilot clinical trial. 基于西罗莫司的狼疮性肾炎诱导治疗:一项单臂、开放标签的试点临床试验
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-18 eCollection Date: 2026-04-01 DOI: 10.1515/jtim-2026-0019
Bo Zou, Pingting Yang
{"title":"Sirolimus-based induction therapy for lupus nephritis: A single-arm, open-label pilot clinical trial.","authors":"Bo Zou, Pingting Yang","doi":"10.1515/jtim-2026-0019","DOIUrl":"https://doi.org/10.1515/jtim-2026-0019","url":null,"abstract":"","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 2","pages":"319-321"},"PeriodicalIF":7.4,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13110455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147788578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell RNA sequencing reveals pancreatic cancer microenvironment heterogeneity for precision therapy. 单细胞RNA测序揭示胰腺癌微环境异质性用于精确治疗。
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-18 eCollection Date: 2026-04-01 DOI: 10.1515/jtim-2026-0013
Yaya Bai, Shimin Wang, Chunhua Zhou, Duowu Zou
{"title":"Single-cell RNA sequencing reveals pancreatic cancer microenvironment heterogeneity for precision therapy.","authors":"Yaya Bai, Shimin Wang, Chunhua Zhou, Duowu Zou","doi":"10.1515/jtim-2026-0013","DOIUrl":"https://doi.org/10.1515/jtim-2026-0013","url":null,"abstract":"","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 2","pages":"167-170"},"PeriodicalIF":7.4,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13110460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147788511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of the triglyceride-glucose index, triglyceride glucose-body mass index, waist-triglyceride index and modified triglyceride-glucose indices with mortality in cardiovascular-kidney-metabolic syndrome stages 0-4: Evidence from NHANES 1999-2020. 甘油三酯-葡萄糖指数、甘油三酯-葡萄糖-体重指数、腰围-甘油三酯指数和改良甘油三酯-葡萄糖指数与心血管-肾脏-代谢综合征0-4期死亡率的关系:来自NHANES 1999-2020的证据
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-13 eCollection Date: 2026-02-01 DOI: 10.1515/jtim-2026-0014
Jingya Zhao, Xinning Lu, Hui Wang, Qin Chen, Yigang Wan
{"title":"Associations of the triglyceride-glucose index, triglyceride glucose-body mass index, waist-triglyceride index and modified triglyceride-glucose indices with mortality in cardiovascular-kidney-metabolic syndrome stages 0-4: Evidence from NHANES 1999-2020.","authors":"Jingya Zhao, Xinning Lu, Hui Wang, Qin Chen, Yigang Wan","doi":"10.1515/jtim-2026-0014","DOIUrl":"https://doi.org/10.1515/jtim-2026-0014","url":null,"abstract":"","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 1","pages":"158-161"},"PeriodicalIF":7.4,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147272832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between free fatty acids and adverse outcomes in patients with and without diabetes undergoing percutaneous coronary intervention. 游离脂肪酸与接受经皮冠状动脉介入治疗的糖尿病患者及非糖尿病患者不良结局的关系
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-13 eCollection Date: 2026-02-01 DOI: 10.1515/jtim-2026-0016
Qinxue Li, Guyu Zeng, Deshan Yuan, Tianyu Li, Peizhi Wang, Ce Zhang, Sida Jia, Pei Zhu, Ying Song, Xiaofang Tang, Ping Liu, Yuejin Yang, Runlin Gao, Jingjing Xu, Xueyan Zhao, Jinqing Yuan
{"title":"Association between free fatty acids and adverse outcomes in patients with and without diabetes undergoing percutaneous coronary intervention.","authors":"Qinxue Li, Guyu Zeng, Deshan Yuan, Tianyu Li, Peizhi Wang, Ce Zhang, Sida Jia, Pei Zhu, Ying Song, Xiaofang Tang, Ping Liu, Yuejin Yang, Runlin Gao, Jingjing Xu, Xueyan Zhao, Jinqing Yuan","doi":"10.1515/jtim-2026-0016","DOIUrl":"https://doi.org/10.1515/jtim-2026-0016","url":null,"abstract":"<p><strong>Background and objectives: </strong>This study aimed to explore the correlation between free fatty acid (FFA) levels and adverse outcomes in patients undergoing percutaneous coronary intervention (PCI) with or without diabetes mellitus.</p><p><strong>Methods: </strong>In total, 10,230 patients treated with PCI were included in this study and divided into three equal groups according to FFA levels (FFA-L, FFA-M, and FFA-H groups). Subsequently, the patients were further stratified based on their diabetes status. A 5-year follow-up was conducted, with the primary endpoint defined as major adverse cardiovascular and cerebrovascular events (MACCE).</p><p><strong>Results: </strong>During follow-up, 2108 (20.6%) patients experienced MACCE. In patients without diabetes, no significant difference was observed in the risk of MACCE among the different FFA groups. However, in patients with diabetes, the risk of MACCE was significantly higher in the FFA-L and FFA-H groups than in the FFA-M group [adjusted hazard ratio (HR), 1.238, 95% confidence interval (CI), 1.054-1.454, <i>P</i> = 0.009; adjusted HR: 1.220, 95% CI, 1.054-1.412, <i>P</i> = 0.008; respectively]. The restricted cubic spline curves showed a nonlinear U-shaped relationship between the FFA levels and the risk of MACCE in patients with diabetes, with the lowest risk observed at an FFA level of 372 μmol/L. The results of the subgroup analysis stratified by different clinical presentations and BMI were similar to those of the primary findings.</p><p><strong>Conclusions: </strong>In patients with diabetes undergoing PCI, both elevated and decreased FFA levels were significantly associated with an increased risk of MACCE. Monitoring FFA levels is essential to help identify those at high risk.</p>","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 1","pages":"53-63"},"PeriodicalIF":7.4,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147272781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feel the force: Biomechanical homeostasis of the cardiovascular system. 感受力:心血管系统的生物力学动态平衡。
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-13 eCollection Date: 2026-02-01 DOI: 10.1515/jtim-2026-0015
Quanyou Shi, Ming Xu, Chi Zhu, Guoping Shi
{"title":"Feel the force: Biomechanical homeostasis of the cardiovascular system.","authors":"Quanyou Shi, Ming Xu, Chi Zhu, Guoping Shi","doi":"10.1515/jtim-2026-0015","DOIUrl":"https://doi.org/10.1515/jtim-2026-0015","url":null,"abstract":"","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 1","pages":"6-9"},"PeriodicalIF":7.4,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147272813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Migrasome as a novel organelle: Biogenesis, physiological functions, and therapeutic potential. 偏头痛小体作为一种新的细胞器:生物发生、生理功能和治疗潜力。
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-13 eCollection Date: 2026-02-01 DOI: 10.1515/jtim-2026-0008
Rumeng Tang, Ling Zhou, Jiaran Lin, Xiangyuan Zhang, Pengfei Xie, Lili Zhang, Linhua Zhao, Xiaolin Tong
{"title":"Migrasome as a novel organelle: Biogenesis, physiological functions, and therapeutic potential.","authors":"Rumeng Tang, Ling Zhou, Jiaran Lin, Xiangyuan Zhang, Pengfei Xie, Lili Zhang, Linhua Zhao, Xiaolin Tong","doi":"10.1515/jtim-2026-0008","DOIUrl":"https://doi.org/10.1515/jtim-2026-0008","url":null,"abstract":"<p><p>Migrasomes are a recently identified type of membranous organelle formed during cell migration. They are produced by migratory cells and widely distributed across various cells and tissues. Migrasomes contain abundant signaling and bioactive molecules, playing crucial roles in embryonic development, angiogenesis, material transport, mitochondrial quality control, and coagulation, as well as participating significantly in numerous pathological processes. This paper provides a detailed overview of the latest advancements in migrasome biology research, including migrasome biogenesis, physiological functions, isolation, and identification, and their roles in the onset, progression, diagnosis, and treatment of clinical diseases. In addition, we propose novel hypotheses and outline future research directions addressing current challenges and potential clinical applications of migrasomes, which may inform their utilization in future clinical diagnostics and therapeutics.</p>","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 1","pages":"34-52"},"PeriodicalIF":7.4,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147272775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model. TMSC-Exo应用肝脏芯片模型治疗非酒精性脂肪肝的潜力
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-13 eCollection Date: 2026-02-01 DOI: 10.1515/jtim-2026-0007
Shujiao He, Kexin Wang, Binghui Li, Wei Fang, Xinyi Wei, Fen Yao, Nan Wang, Xiaoxia Wang, Ying Zhang, Yi Gao, Yang Li, Shao Li, Shuqin Zhou, Juan Du, Qing Peng
{"title":"Therapeutic potential of TMSC-Exo for non-alcoholic fatty liver disease using the liver-on-a-chip model.","authors":"Shujiao He, Kexin Wang, Binghui Li, Wei Fang, Xinyi Wei, Fen Yao, Nan Wang, Xiaoxia Wang, Ying Zhang, Yi Gao, Yang Li, Shao Li, Shuqin Zhou, Juan Du, Qing Peng","doi":"10.1515/jtim-2026-0007","DOIUrl":"https://doi.org/10.1515/jtim-2026-0007","url":null,"abstract":"<p><strong>Background and objectives: </strong>Non-alcoholic fatty liver disease (NAFLD) has become a growing global public health concern. Effective therapeutic strategies for NAFLD remain urgently needed. Liver-on-a-chip (LC) technology offers an innovative platform for NAFLD modeling and drug development. This study aimed to develop a biomimetic liver-chip using co-cultured human hepatocyte (HepaRG) with hepatic stellate and endothelial cells to model NAFLD, and evaluate the therapeutic potential of scalable telomerase reverse transcriptase (hTERT)-immortalized umbilical cord mesenchymal stem cell-derived exosomes (TMSC-Exo).</p><p><strong>Methods: </strong>HepaRG cells, hepatic stellate cells, and endothelial cells were used to construct a dual-chamber biocompatible LC. The NAFLD model was induced by free fatty acid (FFA) and applied to evaluate the efficacy of resmetirom and TMSC-Exo for the treatment of NAFLD. Moreover, the high-fat (HF) diet-induced mouse model was analyzed to verify the in vitro results. Proteomic analyses were performed to explore the molecular mechanisms involved in the development of NAFLD and the effect of TMSC-Exo in treating NAFLD.</p><p><strong>Results: </strong>Cells cultured in LC showed better viability compared to those in the Transwell system. The on-chip NAFLD model mimicked the characteristics of NAFLD <i>in vivo</i>, including intracellular lipid accumulation and impaired hepatocyte functions in albumin synthesis, levels of urea, CYP1A2, and CYP3A4. Both TMSC-Exo and resmetirom displayed a significant effect in reducing the lipid accumulation in the on-chip NAFLD model. The TMSC-Exo showed superior effects in elevating the levels of albumin, urea, CYP1A2, and CYP3A4. The therapeutic effects of TMSC-Exo were also confirmed in the NAFLD mouse models. Proteomic analysis found that the top 15 up- and down-regulated differentially expressed proteins in NAFLD models compared to the control group were mainly associated with lipid metabolism, endoplasmic reticulum stress, and inflammation.</p><p><strong>Conclusions: </strong>Our on-chip NAFLD model successfully recapitulated key pathological features of hepatic steatosis and functional impairment. Using this model, we evaluated TMSC-Exo and demonstrated its significant therapeutic efficacy against NAFLD.</p>","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 1","pages":"134-149"},"PeriodicalIF":7.4,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147272820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Zombie virus" like pyroptosis: Extracellular vesicles spread pyroptosis by transferring functional N-GSDMD pore. “僵尸病毒”样热亡:细胞外囊泡通过转移功能性N-GSDMD孔传播热亡。
IF 7.4 2区 医学
Journal of Translational Internal Medicine Pub Date : 2026-02-13 eCollection Date: 2026-02-01 DOI: 10.1515/jtim-2026-0003
Yihang Zhang, Shumei Jin, Yunfen Tian, Jialong Qi
{"title":"\"Zombie virus\" like pyroptosis: Extracellular vesicles spread pyroptosis by transferring functional N-GSDMD pore.","authors":"Yihang Zhang, Shumei Jin, Yunfen Tian, Jialong Qi","doi":"10.1515/jtim-2026-0003","DOIUrl":"https://doi.org/10.1515/jtim-2026-0003","url":null,"abstract":"","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"14 1","pages":"10-13"},"PeriodicalIF":7.4,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12916272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147272778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书